Procter & Gamble Co (PG) financial statements: income statement, balance sheet and cash flow

Procter & Gamble Co's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Jun 30, 2026 · FY), Procter & Gamble Co reported revenue of $87.0B (+3.3% year on year) and net income of $16.1B (+0.5% year on year).

Income statement

Procter & Gamble Co income statement, fiscal years
Line itemJun 30, 2026 · FYJun 30, 2025 · FYJun 30, 2024 · FYJun 30, 2023 · FY
NET SALES$87.0B$84.3B$84.0B$82.0B
Cost of products sold$43.4B$41.2B$40.8B$42.8B
Selling, general and administrative expense$23.9B$22.7B$23.3B$21.1B
Indefinite-lived intangible asset impairment charge$0$0$1.3B—
OPERATING INCOME$19.7B$20.5B$18.5B$18.1B
Interest expense($877.0M)($907.0M)($925.0M)($756.0M)
Interest income$430.0M$469.0M$473.0M$307.0M
Other non-operating income/(expense), net$1.1B$154.0M$668.0M$668.0M
EARNINGS BEFORE INCOME TAXES$20.4B$20.2B$18.8B—
Income taxes$4.2B$4.1B$3.8B$3.6B
NET EARNINGS$16.1B$16.1B$15.0B$14.7B
Less: Net earnings attributable to noncontrolling interests$98.0M$91.0M$95.0M$85.0M
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE$16.0B$16.0B$14.9B$14.7B
Basic (in dollars per share)$6.75$6.67$6.18$6.07
Diluted (in dollars per share)$6.62$6.51$6.02$5.90
Procter & Gamble Co income statement, quarters
Line itemSep 30, 2026 · Q1Mar 31, 2026 · Q3Dec 31, 2025 · Q2Sep 30, 2025 · Q1
NET SALES$23.3B$21.2B$22.2B$22.4B
Cost of products sold$11.7B$10.7B$10.8B$10.9B
Selling, general and administrative expense$5.7B$5.9B$6.0B$5.6B
OPERATING INCOME$5.9B$4.6B$5.4B$5.9B
Interest expense($223.0M)($223.0M)($220.0M)($197.0M)
Interest income$102.0M$100.0M$115.0M$108.0M
Other non-operating income/(expense), net$207.0M$537.0M$160.0M$268.0M
EARNINGS BEFORE INCOME TAXES$6.0B$5.0B$5.4B$6.0B
Income taxes$1.3B$1.0B$1.1B$1.3B
NET EARNINGS$4.8B$4.0B$4.3B$4.8B
Less: Net earnings attributable to noncontrolling interests$26.0M$18.0M$12.0M$31.0M
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE$4.7B$3.9B$4.3B$4.8B
Basic (in dollars per share)$2.00$1.66$1.82$2.00
Diluted (in dollars per share)$1.97$1.63$1.78$1.95

Balance sheet

Procter & Gamble Co balance sheet, fiscal years
Line itemJun 30, 2026 · FYJun 30, 2025 · FYJun 30, 2024 · FYJun 30, 2023 · FY
Cash and cash equivalents$9.9B$9.6B$9.5B$8.2B
Accounts receivable$6.1B$6.2B$6.1B$5.5B
Materials and supplies$2.1B$2.0B$1.6B$1.9B
Work in process$1.1B$1.0B$929.0M$956.0M
Finished goods$4.9B$4.5B$4.5B$4.3B
Total inventories$8.2B$7.6B$7.0B$7.1B
Prepaid expenses and other current assets$2.0B$2.1B$2.1B$1.9B
TOTAL CURRENT ASSETS$26.2B$25.4B$24.7B$22.6B
PROPERTY, PLANT AND EQUIPMENT, NET$25.4B$23.9B$22.2B$21.9B
GOODWILL$41.3B$41.6B$40.3B$40.7B
TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET$21.4B$21.9B$22.0B$23.8B
OTHER NONCURRENT ASSETS$12.2B$12.4B$13.2B$11.8B
TOTAL ASSETS$126.5B$125.2B$122.4B$120.8B
Accounts payable$16.3B$15.2B$15.4B$14.6B
Accrued and other liabilities$11.1B$11.3B$11.1B$10.9B
Debt due within one year$11.3B$9.5B$7.2B$10.2B
TOTAL CURRENT LIABILITIES$38.7B$36.1B$33.6B$35.8B
LONG-TERM DEBT$22.8B$25.0B$25.3B$24.4B
DEFERRED INCOME TAXES$5.8B$5.8B$6.5B$6.5B
OTHER NONCURRENT LIABILITIES$4.9B$6.1B$6.4B$7.2B
TOTAL LIABILITIES$72.2B$72.9B$71.8B$73.8B
Preferred stock$756.0M$777.0M$798.0M$819.0M
Common stock, stated value $1 per share (10,000 shares authorized; shares issued: 2026 - 4,009.2, 2025 - 4,009.2)$4009000000.00$4009000000.00$4009000000.00$4009000000.00
Additional paid-in capital$69.5B$68.8B$67.7B$66.6B
Reserve for ESOP debt retirement($596.0M)($672.0M)($737.0M)($821.0M)
Accumulated other comprehensive loss($12.5B)($12.1B)($11.9B)$12.2B
Treasury stock (shares held: 2026 -1,685.4; 2025 - 1,667.3)-143.0B-138.7B-133.4B—
Retained earnings$135.9B$130.0B$123.8B$118.2B
Noncontrolling interest$230.0M$272.0M$272.0M$288.0M
TOTAL SHAREHOLDERS' EQUITY$54.3B$52.3B$50.6B$47.1B
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY$126.5B$125.2B$122.4B$120.8B
Procter & Gamble Co balance sheet, quarters
Line itemSep 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025
Cash and cash equivalents$15.4B$12.3B$10.8B$11.2B
Accounts receivable$6.6B$6.3B$6.3B$6.5B
Materials and supplies$2.3B$2.0B$2.1B$2.1B
Work in process$1.1B$1.1B$1.0B$1.0B
Finished goods$5.1B$4.8B$4.7B$4.7B
Total inventories$8.5B$7.9B$7.8B$7.8B
Prepaid expenses and other current assets$2.0B$1.5B$1.7B$1.6B
TOTAL CURRENT ASSETS$32.5B$28.0B$26.6B$27.1B
PROPERTY, PLANT AND EQUIPMENT, NET$25.5B$24.6B$24.5B$24.1B
GOODWILL$41.2B$41.4B$41.7B$41.6B
TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET$21.4B$21.5B$21.7B$21.8B
OTHER NONCURRENT ASSETS$12.5B$12.9B$12.8B$12.9B
TOTAL ASSETS$133.1B$128.4B$127.3B$127.6B
Accounts payable$17.1B$15.0B$15.2B$15.6B
Accrued and other liabilities$10.9B$10.0B$10.5B$10.8B
Debt due within one year$17.0B$13.2B$11.1B$11.6B
TOTAL CURRENT LIABILITIES$45.0B$38.2B$36.7B$38.0B
LONG-TERM DEBT$21.9B$23.9B$25.6B$24.3B
DEFERRED INCOME TAXES$5.9B$6.0B$6.0B$5.9B
OTHER NONCURRENT LIABILITIES$5.0B$5.5B$5.7B$5.8B
TOTAL LIABILITIES$77.8B$73.6B$74.0B$74.0B
Preferred stock$747.0M$759.0M$767.0M$770.0M
Common stock$4.0B$4.0B$4.0B$4.0B
Additional paid-in capital$69.7B$69.4B$69.0B$68.9B
Reserve for ESOP debt retirement($555.0M)($596.0M)($637.0M)($637.0M)
Accumulated other comprehensive loss($12.7B)($12.3B)($12.1B)($12.2B)
Treasury stock($144.2B)($142.2B)($142.0B)($139.8B)
Retained earnings$138.0B$135.4B$134.0B$132.2B
Noncontrolling interest$239.0M$226.0M$276.0M$281.0M
TOTAL SHAREHOLDERS’ EQUITY$55.3B$54.7B$53.3B$53.6B
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY$133.1B$128.4B$127.3B$127.6B

Cash flow statement

Procter & Gamble Co cash flow statement, fiscal years
Line itemJun 30, 2026 · FYJun 30, 2025 · FYJun 30, 2024 · FYJun 30, 2023 · FY
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF YEAR$9.6B$9.5B$8.2B$7.2B
Net earnings$16.1B$16.1B$15.0B$14.7B
Depreciation and amortization$3.2B$2.8B$2.9B$2.7B
Share-based compensation expense$524.0M$476.0M$562.0M$545.0M
Deferred income taxes$51.0M$149.0M($244.0M)($453.0M)
(Gain)/loss on sale of assets($351.0M)$755.0M($215.0M)$40.0M
Indefinite-lived intangible asset impairment charge$0$0$1.3B—
Change in accounts receivable$84.0M$45.0M($766.0M)($307.0M)
Change in inventories($641.0M)($324.0M)($70.0M)($119.0M)
Change in accounts payable$919.0M($542.0M)——
Other($333.0M)($1.7B)$969.0M—
TOTAL OPERATING ACTIVITIES$19.6B$17.8B$19.8B$16.8B
Capital expenditures($4.4B)($3.8B)($3.3B)($3.1B)
Proceeds from asset sales$508.0M$107.0M$346.0M$46.0M
Acquisitions, net of cash acquired($85.0M)($11.0M)($21.0M)($765.0M)
Other investing activity($638.0M)($141.0M)($507.0M)$281.0M
TOTAL INVESTING ACTIVITIES($4.6B)($3.8B)($3.5B)($3.5B)
Dividends to shareholders($10.2B)($9.9B)($9.3B)($9.0B)
Additions to short-term debt with original maturities of more than three months$7.9B$8.0B$3.5B$17.2B
Reductions in short-term debt with original maturities of more than three months($10.0B)($6.5B)($7.7B)($13.0B)
Net additions/(reductions) to other short-term debt$2.7B($1.1B)$857.0M($3.3B)
Additions to long-term debt$2.7B$2.2B$3.2B$4.0B
Reductions in long-term debt($3.4B)($2.0B)($2.3B)($1.9B)
Treasury stock purchases($5.0B)($6.5B)($5.0B)($7.4B)
Impact of stock options and other$907.0M$1.7B$1.9B$1.3B
TOTAL FINANCING ACTIVITIES($14.5B)($14.0B)($14.9B)($12.1B)
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH($86.0M)$112.0M($251.0M)($170.0M)
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH$386.0M$75.0M$1.2B$1.0B
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD$9.9B$9.6B——
Cash payments for interest$866.0M$896.0M$878.0M—
Procter & Gamble Co cash flow statement, quarters
Line itemSep 30, 2026 · Q1Mar 31, 2026 · YTDDec 31, 2025 · YTDSep 30, 2025 · Q1
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD$9.9B$9.6B$9.6B$9.6B
Net earnings$4.8B$13.1B$9.1B$4.8B
Depreciation and amortization$810.0M$2.3B$1.6B$761.0M
Share-based compensation expense$98.0M$394.0M$262.0M$121.0M
Deferred income taxes$115.0M$178.0M$196.0M$53.0M
(Gain)/loss on sale of assets($20.0M)($345.0M)$1.0M($3.0M)
Change in accounts receivable($589.0M)($186.0M)($92.0M)($305.0M)
Change in inventories($349.0M)($346.0M)($255.0M)($303.0M)
Change in accounts payable$1.1B$196.0M$239.0M$648.0M
Other($204.0M)($877.0M)($645.0M)($344.0M)
TOTAL OPERATING ACTIVITIES$5.8B$14.4B$10.4B$5.4B
Capital expenditures($1.4B)($3.4B)($2.4B)($1.2B)
Proceeds from asset sales$27.0M$501.0M$16.0M$8.0M
Acquisitions, net of cash acquired$0($85.0M)($5.0M)($5.0M)
Other investing activity($121.0M)($458.0M)($408.0M)($338.0M)
TOTAL INVESTING ACTIVITIES($1.5B)($3.4B)($2.8B)($1.5B)
Dividends to shareholders($2.6B)($7.6B)($5.1B)($2.5B)
Additions to short-term debt with original maturities of more than three months$0$7.8B$4.2B$1.1B
Reductions in short-term debt with original maturities of more than three months($157.0M)($6.4B)($3.3B)($1.8B)
Net additions/(reductions) to other short-term debt$5.8B$1.0B($471.0M)$2.1B
Reductions in long-term debt($747.0M)($2.4B)($1.0B)($3.0M)
Treasury stock purchases($1.3B)($4.2B)($3.5B)($1.3B)
Impact of stock options and other$143.0M$872.0M$208.0M$134.0M
TOTAL FINANCING ACTIVITIES$1.1B($8.2B)($6.3B)($2.2B)
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH($29.0M)($94.0M)($21.0M)($20.0M)
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH$5.4B$2.7B$1.3B$1.6B
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD$15.4B$12.3B$10.8B$11.2B

Procter & Gamble Co score and earnings-call analysis · All covered companies

Figures as reported in SEC filings. General information, not investment advice.